Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells

[1]  J. Davis,et al.  Effects of 5-fluorouracil chemotherapy on fatigue: Role of MCP-1 , 2013, Brain, Behavior, and Immunity.

[2]  T. Nakagawa,et al.  5-Fluorouracil Induces Diarrhea with Changes in the Expression of Inflammatory Cytokines and Aquaporins in Mouse Intestines , 2013, PloS one.

[3]  A. Stringer,et al.  Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors , 2013, Experimental biology and medicine.

[4]  D. C. Cara,et al.  Oral Supplementation of Butyrate Reduces Mucositis and Intestinal Permeability Associated with 5-Fluorouracil Administration , 2012, Lipids.

[5]  M. Geier,et al.  Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage , 2012, Supportive Care in Cancer.

[6]  Yi-Fang Huang,et al.  5-Fluorouracil Induced Intestinal Mucositis via Nuclear Factor-κB Activation by Transcriptomic Analysis and In Vivo Bioluminescence Imaging , 2012, PloS one.

[7]  M. Gangidine,et al.  Proinflammatory Chemokines in the Intestinal Lumen Contribute to Intestinal Dysfunction During Endotoxemia , 2012, Shock.

[8]  F. Cunha,et al.  Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice , 2011, Cancer Chemotherapy and Pharmacology.

[9]  Y. Schneider,et al.  Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium. , 2010, Chemico-biological interactions.

[10]  H. Friess,et al.  Interleukin-10 and -12 Predict Chemotherapy-Associated Toxicity in Esophageal Adenocarcinoma , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  M. Łukaszewicz,et al.  The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407. , 2010, FEMS microbiology letters.

[12]  H. Yamanaka-Okumura,et al.  Protective effects of glycoglycerolipids extracted from spinach on 5-fluorouracil induced intestinal mucosal injury. , 2010, The journal of medical investigation : JMI.

[13]  H. Fang,et al.  Inhibitory effects of Lactobacillus casei subsp. rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells. , 2010, Journal of medical microbiology.

[14]  M. Gareau,et al.  Lactobacillus rhamnosus GG attenuates interferon-c and tumour necrosis factor-a-induced barrier dysfunction and pro-inflammatory signalling , 2010 .

[15]  J. Neu,et al.  Live and Heat-Killed Lactobacillus rhamnosus GG: Effects on Proinflammatory and Anti-Inflammatory Cytokines/Chemokines in Gastrostomy-Fed Infant Rats , 2009, Pediatric Research.

[16]  J. Kaper,et al.  The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection , 2009, Cellular microbiology.

[17]  M. Thirabunyanon,et al.  Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells , 2009, Biotechnology Letters.

[18]  M. Geier,et al.  Lactobacillus fermentum BR11 and Fructo-Oligosaccharide Partially Reduce Jejunal Inflammation in a Model of Intestinal Mucositis in Rats , 2008, Nutrition and cancer.

[19]  M. Totsuka,et al.  Cytokine Responses of Intestinal Epithelial-Like Caco-2 Cells to Non-Pathogenic and Opportunistic Pathogenic Yeasts in the Presence of Butyric Acid , 2007, Bioscience, biotechnology, and biochemistry.

[20]  H. Joensuu,et al.  Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study , 2007, British Journal of Cancer.

[21]  S. Sonis,et al.  The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. , 2007, Cancer treatment reviews.

[22]  H. Szajewska,et al.  Meta‐analysis: Lactobacillus GG for treating acute diarrhoea in children , 2007, Alimentary pharmacology & therapeutics.

[23]  M. Geier,et al.  Probiotic Effects on 5-Fluorouracil-Induced Mucositis Assessed by the Sucrose Breath Test in Rats , 2007, Digestive Diseases and Sciences.

[24]  C. Jun,et al.  Gliotoxin reduces the severity of trinitrobenzene sulfonic acid‐induced colitis in mice: Evidence of the connection between heme oxygenase‐1 and the nuclear factor‐&kgr;B pathway in vitro and in vivo , 2006, Inflammatory Bowel Diseases.

[25]  J. Mrukowicz,et al.  Probiotics in Gastrointestinal Diseases in Children: Hard and Not-So-Hard Evidence of Efficacy , 2006, Journal of pediatric gastroenterology and nutrition.

[26]  Jing-GangLan,et al.  Different cytokine response of primary colonic epithelial cells to commensal bacteria , 2005 .

[27]  G. V. Ramana,et al.  Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer. , 2004, Neoplasia.

[28]  L. Elting,et al.  Perspectives on cancer therapy‐induced mucosal injury , 2004, Cancer.

[29]  R. Buelow,et al.  Oral RDP58 Allows CPT-11 Dose Intensification for Enhanced Tumor Response by Decreasing Gastrointestinal Toxicity , 2004, Clinical Cancer Research.

[30]  K. Rolston.  The burdens of cancer therapy , 2004, Cancer.

[31]  D. Keefe.  Gastrointestinal mucositis: a new biological model , 2004, Supportive Care in Cancer.

[32]  J. Stein,et al.  Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2 , 2003, European journal of nutrition.

[33]  M. Jontell,et al.  Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. , 2003, Oral microbiology and immunology.

[34]  Scott B Cantor,et al.  The burdens of cancer therapy , 2003, Cancer.

[35]  T. Humphrey,et al.  Morphological Changes to Escherichia Coli O157:H7, Commensal E. coli and Salmonella spp in Response to Marginal Growth Conditions, with Special Reference to Mildly Stressing Temperatures , 2003, Science progress.

[36]  S. Jiang,et al.  Multicenter randomized controlled trial of heat‐killed Lactobacillus acidophilus LB in patients with chronic diarrhea , 2002 .

[37]  A. Smith,et al.  Yoghurt biotherapy: contraindicated in immunosuppressed patients? , 2002, Postgraduate medical journal.

[38]  I. Lubensky,et al.  Combination interleukin-2 and interleukin-12 induces severe gastrointestinal toxicity and epithelial cell apoptosis in mice. , 2002, Cytokine.

[39]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[40]  W. Hammes,et al.  Activation of Human Peripheral Blood Mononuclear Cells by Nonpathogenic Bacteria In Vitro: Evidence of NK Cells as Primary Targets , 2000, Infection and Immunity.

[41]  R. Macdermott,et al.  Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. , 1995, Gastroenterology.

[42]  K. Nomoto,et al.  Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation. , 1992, Canadian journal of microbiology.